Tobacco use is the leading preventable cause of death and disease in our society, and the
prevalence of smoking in individuals with schizophrenia is significantly higher than in the …

This study was designed to determine the feasibility and efficacy of long-term nicotine
replacement therapy (NRT) in helping persons with schizophrenia remain tobacco-free. Fifty …

Nicotine use is a major public health problem that increases medical morbidity and mortality.
Nicotine's action and the pathobiology of schizophrenic disorders have common …

There have been many studies of smoking cessation using nicotine replacement therapy
(NRT) with schizophrenic patients, but none exploring the smoking-reduction effects of …

Introduction Rates of tobacco smoking are high in people with schizophrenia with greater
difficulty of quitting smoking compared to the general population, which also relate to the …

Although patients with have low motivations to quit smoking, smoking cessation treatment
can be effective for these patients. Patients schizophrenia who achieve significant smoking …

Smoking cessation is a chronic issue surrounding individuals with schizophrenia. It is
estimated that up to 90% of patients diagnosed with schizophrenia smoke cigarettes. The …

Cigarette smoking continues to adversely affect the health of individuals with schizophrenia.
Both smoking and heavy nicotine dependence, given the complex biological findings, might …

Objective: High rates of smoking and nicotine dependence have a profoundly negative
impact on the health and well being of individuals with schizophrenia. Treating smoking is a …

The paper by McChargue et al.(2002) raises an important question regarding the treatment
of tobacco addiction in schizophrenia—whether smoking abstinence or smoking reduction …